scispace - formally typeset
Open AccessJournal ArticleDOI

2017 ESC/EACTS Guidelines for the management of valvular heart disease

Reads0
Chats0
About
This article is published in European Heart Journal.The article was published on 2017-09-21 and is currently open access. It has received 4790 citations till now. The article focuses on the topics: valvular heart disease.

read more

Citations
More filters
Journal ArticleDOI

Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis.

TL;DR: Bioprosthetic valves may be associated with a higher risk of infective endocarditis, and should help guide the discussion when deciding between bioprosthetic and mechanical valves in individual patients.
Journal ArticleDOI

Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation

TL;DR: This review provides a comprehensive overview of the available data on antithrombotic therapy after transcatheter aortic valve implantation (TAVI) and recommends single rather than dual APT as the first-line treatment of patients undergoing TAVI.
Journal ArticleDOI

Percutaneous interventions for mitral and tricuspid heart valve diseases

TL;DR: Although the development of transcatheter strategies for tricuspid regurgitation (TR) is still in the early stages, there is growing evidence to support the application of various approaches, including edge-to-edge repair and annuloplasty, to address unmet needs.
References
More filters
Journal ArticleDOI

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)
Journal ArticleDOI

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

TL;DR: In patients with severe aortic stenosis who were not suitable candidates for surgery, TAVI, as compared with standard therapy, significantly reduced the rates of death from any cause, the composite end point of deathFrom any cause or repeat hospitalization, and cardiac symptoms, despite the higher incidence of major strokes and major vascular events.
Related Papers (5)